Skip to main content
. 2017 Jan 31;7:2. doi: 10.1186/s13569-017-0066-6

Table 3.

Interventions for VAD related adverse events per venous access device

N (%) Antibiotics (oral) VAD replaced Wait-and-see Analgesics Urokinase (IV) Antibiotics (IV)
Venous access port (102) 19 (18.6) 10 (9.8) 13 (12.7) 8 (7.8) 8 (7.8) 2 (2.0)
Hickman line (15) 1 (6.7) 6 (40.0) 3 (20.0) 2 (13.3) 1 (6.7) 0 (0.0)
PICC line (10) 2 (20.0) 3 (30.0) 1 (10.0) 0 (0.0) 0 (0.0) 3 (30.0)
Total 22 (17.3) 19 (15.0) 17 (13.4) 10 (7.9%) 9 (7.1) 5 (3.9)